SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

47 hedge funds and large institutions have $240M invested in Sierra Oncology, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
1.23%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
18
Increased
13
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
1
Deerfield Management
New York
$26.9M
2
BFA
2
BlackRock Fund Advisors
California
$5.32M
3
GT
3
Greenleaf Trust
Michigan
$2.87M
4
RIM
4
RS Investment Management
California
$10.5M
5
QF
5
QVT Financial
New York
$1.05M

Top Sellers

1
HCM
1
Hayman Capital Management
Texas
$0
2
Jennison Associates
2
Jennison Associates
New York
$0
3
VM
3
VHCP Management
New York
$1.13M
4
Millennium Management
4
Millennium Management
New York
$0
5
BA
5
BlackRock Advisors
Delaware
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BA
51
BlackRock Advisors
Delaware
– -$1.67M -2,038 Closed
CS
52
Credit Suisse
Switzerland
– -$476K -580 Closed
BG
53
BlackRock Group
United Kingdom
– -$198K -241 Closed
BIM
54
BlackRock Investment Management
Delaware
– -$109K -133 Closed
Bank of Montreal
55
Bank of Montreal
Ontario, Canada
– -$103K -125 Closed
UBS Group
56
UBS Group
Switzerland
– -$8K -10 Closed
1 2
3